A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells

Oncogene
C CraigP Seth

Abstract

In order to elucidate the biochemical mechanisms by which the universal cyclin kinase inhibitor p27Kip1 regulates cell cycle progression in human breast cancer cells, a recombinant adenovirus expressing human p27 was constructed (Adp27). Upon infection of human breast cancer cells MDA-MB-231 and MCF-7 with Adp27, a high level of p27 expression was observed, and this resulted in a marked decrease in the proportion of cells in S-phase. In multiple cell lines, comparison of the cytotoxicity of Adp27 with another adenovirus vector expressing the related universal cyclin kinase inhibitor WAF1/Cip1 (AdWAF1), showed Adp27 to be markedly more (up to 56-fold) toxic than AdWAF1. DNA histograms showed Adp27 to cause a G1/S arrest at lower viral doses than AdWAF1. Analysis of cyclin dependent kinase activity following Adp27 infections showed decreased Cdk2 and cyclin B1-Cdc2 activity at lower viral doses when compared with AdWAF1. Adp27 is therefore potentially useful for studies of growth regulation and for gene therapy when growth inhibition is desired.

Citations

Aug 4, 1998·International Journal of Cancer. Journal International Du Cancer·M T Dimanche-BoitrelE Solary
Mar 4, 2000·Journal of Cellular Physiology·A SgambatoI B Weinstein
Sep 27, 2000·International Journal of Cancer. Journal International Du Cancer·C GaoS Srivastava
Sep 15, 2006·Cancer Chemotherapy and Pharmacology·D HenleyJ Wimalasena
Dec 6, 2005·Journal of Cancer Research and Clinical Oncology·Annette Schmider-RossAngela Reles
Mar 26, 2003·Brain Research. Molecular Brain Research·Baolin LiRugao Liu
Oct 23, 1998·Molecular and Cellular Endocrinology·L VerlindenR Bouillon
Mar 11, 1999·Current Opinion in Genetics & Development·M D Garrett, A Fattaey
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·R D Meng, W S El-Deiry
Jan 18, 2006·Cancer Gene Therapy·M A Stoff-KhaliliD T Curiel
Aug 31, 1999·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M YasunagaN Kitamura
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S ErkanliB Demirhan
Apr 8, 1999·Molecular Pathology : MP·P L FernándezA Cardesa
May 10, 2007·Cell Division·Irina NickeleitNisar P Malek
Aug 21, 2004·Breast Cancer Research : BCR·Iain BrownAndrew C Schofield
Jul 23, 2005·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·Hatice TigliNejat Dalay
Sep 9, 2004·Journal of Neurosurgery·Kyung-Ho ParkChoon-Taek Lee
Oct 16, 2008·World Journal of Gastroenterology : WJG·Ze-Qun SunYong Du
Jun 13, 2009·World Journal of Gastroenterology : WJG·Jun ChenChang-Sheng Deng
Dec 18, 2012·Reproduction : the Official Journal of the Society for the Study of Fertility·Susan M QuirkRebecca M Harman
Apr 24, 2013·Targeted Oncology·Robert M SutphinRiyaz Basha
Feb 13, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·K H ParkC T Lee
Mar 7, 2006·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiroshi HaradaMasahiro Hiraoka
Jul 3, 2013·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·S T GezgincM C Colakoglu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.